Is the U.K. Losing Its Competitive Edge in Life Sciences Amid Merck's Exit?

Is the U.K. Losing Its Edge in Life Sciences as Merck Exits?

Merck’s recent decision to withdraw significant operations from the United Kingdom has raised fresh concerns about the country’s ability to maintain its standing as a global hub for life sciences. Once regarded as a prime destination for biotech and pharmaceutical investment, the U.K. now faces mounting challenges amid shifting economic policies, regulatory uncertainties, and competitive [...]

Is the U.K. Losing Its Competitive Edge in Life Sciences Amid Merck's Exit?

Merck’s recent decision to withdraw significant operations from the United Kingdom has raised fresh concerns about the country’s ability to maintain its standing as a global hub for life sciences. Once regarded as a prime destination for biotech and pharmaceutical investment, the U.K. now faces mounting challenges amid shifting economic policies, regulatory uncertainties, and competitive pressures from other international markets. This move by o…

Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector?

Merck’s decision to back out of its $1 billion expansion comes as U.K. investments in life sciences declines. The post Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector?  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may b…